Ansbert Gadicke - Insider Trading & Ownership

Entity
Individual
Location
The John Hancock Tower, 200 Clarendon Street, 54 Th Floor, Boston, MA
Summary
The estimated net worth of Ansbert Gadicke is at least $306M dollars as of June 5, 2023. Ansbert Gadicke is the 10%+ Owner of Harpoon Therapeutics, Inc. and owns shares of Harpoon Therapeutics, Inc. stock worth about $146M. Ansbert Gadicke is the Director of Cullinan Oncology, Inc. and owns shares of Cullinan Therapeutics, Inc. (CGEM) stock worth about $103M. Ansbert Gadicke is the 10%+ Owner of iTeos Therapeutics, Inc. and owns shares of iTeos Therapeutics, Inc. (ITOS) stock worth about $37.5M. Ansbert Gadicke is the Director, 10%+ Owner of Allovir, Inc. and owns shares of Allovir, Inc. (ALVR) stock worth about $11.2M. Ansbert Gadicke is the 10%+ Owner of Repare Therapeutics Inc. and owns shares of Repare Therapeutics Inc. (RPTX) stock worth about $9.42M.
All Insider Reports
All Insider Reports

Ownership of Ansbert Gadicke

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
HARP Harpoon Therapeutics, Inc. 10%+ Owner $146M May 28, 2021
CGEM Cullinan Therapeutics, Inc. Director $103M Jun 22, 2022
ITOS iTeos Therapeutics, Inc. 10%+ Owner $37.5M Jan 4, 2022
ALVR Allovir, Inc. Director, 10%+ Owner $11.2M Jul 28, 2022
RPTX Repare Therapeutics Inc. 10%+ Owner $9.42M Jul 9, 2021
TCRR TCR2 THERAPEUTICS INC. Director, 10%+ Owner Jun 1, 2023

Insider Transactions Reported by Ansbert Gadicke:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.